Health Plans Looking To Isolate Specialty Drug Costs From Medical Benefit
Executive Summary
Health plans are moving away from traditional practices of bundling coverage for specialty drugs with physician and other medical costs, according to Medco's 2008 Drug Trend Report
You may also be interested in...
WellCare Government Membership Up But Costs May Lead To Loss
WellCare anticipates a net loss in the first quarter 2008, versus net income of $25 million in the first quarter of 2007, due to higher medical expenses and costs associated with ongoing government and special committee investigations
Medco’s Critical Care Systems Purchase Will Build Infusion Market Presence
Medco is aiming to expand its presence in the specialty infusion market with the acquisition of Critical Care Systems, a provider of home-based and ambulatory specialty infusion services
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.